« BackAmerican Journal of Obstetrics & Gynecology
Article in Press

The FIGO systems for nomenclature and classification of causes of abnormal uterine bleeding in the reproductive years: who needs them?

  • Malcolm G. Munro, MD

      Affiliations

    • Department of Obstetrics & Gynecology, David Geffen School of Medicine at UCLA, Kaiser Permanente, Southern California, Los Angeles, CA
  • ,
  • Hilary O.D. Critchley, MD

      Affiliations

    • Department of Obstetrics & Gynecology, David Geffen School of Medicine at UCLA, Kaiser Permanente, Southern California, Los Angeles, CA
    • MRC Centre for Reproductive Health, The University of Edinburgh, The Queen's Medical Research Institute, Edinburgh, United Kingdom
    • Corresponding Author InformationReprints: not available from the authors
  • ,
  • Ian S. Fraser, MD

      Affiliations

    • Department of Obstetrics, Gynaecology and Neonatology, Queen Elizabeth II, Research Institute for Mothers and Infants, University of Sydney, Camperdown, Australia

Received 29 November 2011; received in revised form 13 January 2012; accepted 31 January 2012. published online 10 February 2012.
Corrected Proof

In November 2010, the International Federation of Gynecology and Obstetrics formally accepted a new classification system for causes of abnormal uterine bleeding in the reproductive years. The system, based on the acronym PALM-COEIN (polyps, adenomyosis, leiomyoma, malignancy and hyperplasia–coagulopathy, ovulatory disorders, endometrial causes, iatrogenic, not classified) was developed in response to concerns about the design and interpretation of basic science and clinical investigation that relates to the problem of abnormal uterine bleeding. A system of nomenclature for the description of normal uterine bleeding and the various symptoms that comprise abnormal bleeding has also been included. This article describes the rationale, the structured methods that involved stakeholders worldwide, and the suggested use of the International Federation of Gynecology and Obstetrics system for research, education, and clinical care. Investigators in the field are encouraged to use the system in the design of their abnormal uterine bleeding–related research because it is an approach that should improve our understanding and management of this often perplexing clinical condition.

Key words:  abnormal uterine bleeding , classification system , FIGO , heavy menstrual bleeding , leiomyoma

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Funded by an unrestricted educational grant to the Association of Academic Health Centers from TAP Pharmaceuticals, Chicago, IL, and Schering AG, Berlin, Germany; subsequent funding was provided by an unrestricted grant to the Royal Australian and New Zealand College of Obstetricians and Gynaecologists by Bayer Women's Health, Berlin, Germany.

 All authors act as consultants to Bayer Health Care; H.O.D.C. has received support for research collaboration from Bayer Pharma AG and also past support (research grant) from TAP Pharmaceutical Products Inc; I.S.F. has received research grants from Bayer Health Care.

PII: S0002-9378(12)00140-8

doi:10.1016/j.ajog.2012.01.046

« BackAmerican Journal of Obstetrics & Gynecology